PIOMBINO DESE, Italy-- (BUSINESS WIRE)--Mar 12, 2026-- ...
“At the early stage, you’ve got to be hands-on, get involved with everything and everyone, and really understand your own limitations,” he added. For emerging biotechs, this combination of strategic ...
Where will Trump be today in Cincinnati? What to know about the area businesses.
Pharmaceutical companies in India are driving innovation, biosimilars, APIs & global exports while strengthening research, manufacturing & healthcare access.
Foreign facilities failed FDA GMP inspections at up to 1.8x the U.S. rate. Journal of Pharmaceutical Innovation study ...
CNS Pharma wipes glioblastoma pipeline clean in strategic pivot to fresh neurology, oncology targets
“Strategic transformations are a common and often successful approach in biotechnology,” Rami Levin, who took over as CEO of ...
This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content. The placement of ...
KALA BIO (KALA) stock soared 70% pre-market after revealing plans to launch its first commercial AI agent in 14 days through ...
In 2016, millions of Americans supported Donald Trump for a simple reason: He felt real. He wasn’t polished. He wasn’t scripted. In fact, the lack of polish was part of the appeal. Trump spoke bluntly ...
Learn more about whether Catalyst Pharmaceuticals, Inc. or Xenon Pharmaceuticals Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Dr. Robert Lenz brings over 20 years of experience in neuroscience drug development ...
Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly reduced the frequency of those seizures compared to a placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results